Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been making waves in the healthcare sector with its groundbreaking treatments for ...
Target’s DEI rollback raises questions about the retail giant’s philanthropic commitments
Target’s rollback on diversity, equity and inclusion initiatives is raising questions about the retail giant’s philanthropic ...
Indivior names Dr. David Wheadon as new board chair
RICHMOND, VA - Indivior PLC (LON:INDV), a pharmaceutical company specializing in treatments for substance use disorders, ...
Eli Lilly price target lowered to $1,190 from $1,250 at Citi
Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...
PMX: Has Been Falling Short, Which I Expect To Continue In 2025 (Rating Downgrade)
Despite a 5.8% discount to NAV, PMX's valuation has narrowed since 2024. Read why I downgrade the fund from buy to hold.
Madison Courier3d
Tracey Allen Franks
Tracey Allen Franks, age 59, of Indianapolis, IN, was born on Nov. 26, 1965, in Seymour, IN, to parents Bruce and Virginia ...